Acronyms that contain the term repligen 

Repligen

Repligen Corporation (Repligen) is a biopharmaceutical company focused on the development and commercialization of therapies that harness biological pathways and deliver value to patients and clinicians in neurology, gastroenterology and orphan diseases. As of March 31, 2010, the Company was conducting a number of drug development programs for diseases, such as pancreatitis, bipolar disorder, Friedreich™s ataxia and spinal muscular atrophy. It also has a bioprocessing business that focuses on the development and commercialization of products that are used for the production of biopharmaceuticals. Repligen sells a line of commercial bioprocessing products based on Protein A, as well as single or limited campaign use pre-packed chromatography columns, which are used in the production of monoclonal antibodies and other biopharmaceutical manufacturing applications. In March 2010, the Company announced that it acquired the assets of BioFlash Partners, LLC, (BioFlash).

see more »